Canada markets open in 7 hours 56 minutes

Rhythm Pharmaceuticals, Inc. (RYTM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
43.76+2.78 (+6.78%)
At close: 04:00PM EDT
43.76 0.00 (0.00%)
After hours: 04:21PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.67B
Enterprise Value 2.39B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)32.60
Price/Book (mrq)15.72
Enterprise Value/Revenue 30.91
Enterprise Value/EBITDA -14.21

Trading Information

Stock Price History

Beta (5Y Monthly) 1.93
52-Week Change 3145.83%
S&P500 52-Week Change 322.38%
52 Week High 352.57
52 Week Low 315.50
50-Day Moving Average 341.01
200-Day Moving Average 334.26

Share Statistics

Avg Vol (3 month) 3565.86k
Avg Vol (10 day) 3491.49k
Shares Outstanding 560.97M
Implied Shares Outstanding 660.97M
Float 844.98M
% Held by Insiders 10.54%
% Held by Institutions 1115.98%
Shares Short (Apr 15, 2024) 410.2M
Short Ratio (Apr 15, 2024) 416.58
Short % of Float (Apr 15, 2024) 427.23%
Short % of Shares Outstanding (Apr 15, 2024) 416.96%
Shares Short (prior month Mar 15, 2024) 49.2M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -238.52%
Operating Margin (ttm)-170.28%

Management Effectiveness

Return on Assets (ttm)-32.22%
Return on Equity (ttm)-85.10%

Income Statement

Revenue (ttm)77.43M
Revenue Per Share (ttm)1.34
Quarterly Revenue Growth (yoy)175.70%
Gross Profit (ttm)N/A
EBITDA -182.6M
Net Income Avi to Common (ttm)-184.68M
Diluted EPS (ttm)-3.20
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)275.85M
Total Cash Per Share (mrq)4.59
Total Debt (mrq)107.4M
Total Debt/Equity (mrq)63.27%
Current Ratio (mrq)5.58
Book Value Per Share (mrq)2.86

Cash Flow Statement

Operating Cash Flow (ttm)-136.16M
Levered Free Cash Flow (ttm)-91.47M